HomeCompareCMTX vs PFE

CMTX vs PFE: Dividend Comparison 2026

CMTX yields 38.46% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CMTX wins by $162.1K in total portfolio value
10 years
CMTX
CMTX
● Live price
38.46%
Share price
$5.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$213.1K
Annual income
$34,859.06
Full CMTX calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — CMTX vs PFE

📍 CMTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCMTXPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CMTX + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CMTX pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CMTX
Annual income on $10K today (after 15% tax)
$3,269.23/yr
After 10yr DRIP, annual income (after tax)
$29,630.20/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, CMTX beats the other by $6,501.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CMTX + PFE for your $10,000?

CMTX: 50%PFE: 50%
100% PFE50/50100% CMTX
Portfolio after 10yr
$132.1K
Annual income
$31,034.80/yr
Blended yield
23.49%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

CMTX
No analyst data
Altman Z
41.3
Piotroski
2/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CMTX buys
0
PFE buys
0
No recent congressional trades found for CMTX or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCMTXPFE
Forward yield38.46%6.20%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$213.1K$51.1K
Annual income after 10y$34,859.06$27,210.54
Total dividends collected$158.5K$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CMTX vs PFE ($10,000, DRIP)

YearCMTX PortfolioCMTX Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$14,546$3,846.15$9,161$701.38+$5.4KCMTX
2$20,793$5,228.67$8,610$859.79+$12.2KCMTX
3$29,234$6,985.18$8,366$1,081.25+$20.9KCMTX
4$40,458$9,178.25$8,483$1,405.66+$32.0KCMTX
5$55,162$11,871.34$9,084$1,907.24+$46.1KCMTX
6$74,150$15,126.76$10,418$2,732.78+$63.7KCMTX
7$98,344$19,003.53$13,007$4,193.56+$85.3KCMTX
8$128,783$23,555.24$18,010$7,005.87+$110.8KCMTX
9$166,626$28,828.07$28,216$12,979.89+$138.4KCMTX
10$213,149$34,859.06$51,081$27,210.54+$162.1KCMTX

CMTX vs PFE: Complete Analysis 2026

CMTXStock

Comtex News Network, Inc. provides electronic real-time news, and content and proprietary market products in the United States. The company receives, enhances, combines, and filters news and content received from national and international news bureaus, agencies, and publications. Its products comprise CustomWires, the real-time and subject-specific newswires, such as finance, business, foreign exchange, and public companies, as well as real-time trading data in the global stock markets, commodities and futures prices, SEC filing information, personal investment news, economic indicator data, international trade policies, business news, IRS bulletins, and actions from the global financial institutions; and Comtex Top News that include editorial news summaries in 29 categories. The company also provides feed products and custom solutions; and SmarTrend products for managing investments. Comtex News Network, Inc. is based in New York, New York.

Full CMTX Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this CMTX vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CMTX vs SCHDCMTX vs JEPICMTX vs OCMTX vs KOCMTX vs MAINCMTX vs JNJCMTX vs MRKCMTX vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.